Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Veryan Medical has developed and commercialized the BioMimics 3D Vascular Stent System, a self-expanding nitinol stent with a unique 3D helical geometry. This device is clinically proven to improve patency in patients with symptomatic peripheral arterial disease of the lower limbs. The technology received CE Mark approval in November 2012 and has demonstrated positive results in multicenter randomized clinical trials (the Mimics study).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Veryan Medical.